All In MedTech

Device Trial Radar · NCT06942325

Performance and Effectiveness of a Self-fitting Over-the-counter Hearing Aid

Performance and Effectiveness of a Self-fitting Over-the-counter Hearing Aid in Adults With Perceived Mild-Moderate Hearing Loss: A Three Phased Approach

Last checked: Nov 20, 2026Latest source record: Nov 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Sep 1, 2025

Primary completion

Dec 31, 2025

Study completion Dec 31, 2025

Sponsor

Lead sponsor
HearX SANot on our public-company list
Sponsor type
Industry
First posted
Apr 24, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Other
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 110 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Hearing loss significantly affects quality of life, with sensorineural hearing loss being the most common type among adults. Hearing aids are a proven intervention, yet barriers like access and affordability limit their adoption, even in high-income countries with developed audiological services . Traditionally, hearing aids required professional consultations, restricting access. However, in 2022, the U.S. FDA approved over-the-counter (OTC) hearing aids, including self-fitting devices, to improve accessibility. Recent clinical trials suggest that OTC hearing aids can deliver similar benefits to professionally fitted ones in speech recognition and self-reported outcomes. Critiques of these studies have focused on using the same device model for both groups rather than comparing it to established prescription hearing aids. To address this, the current study employs a phased approach. Phase 1 validates an in-situ hearing test against a standard audiometer, Phase 2 assesses user experience, and Phase 3 involves a randomized control trial comparing a self-fitting OTC hearing aid with a professionally fitted prescription device. The hypothesis is that both devices offer equivalent benefits. This research is novel as no previous studies have directly compared self-fitting OTC and commercially available prescription hearing aids. This study will compare the effectiveness of an OTC self-fitting hearing aid against a prescription device using a crossover randomized control trial.

Conditions

  • Hearing Loss
  • Hearing Impairment

Interventions

  • OTC self-fitting hearing aidDevice

    OTC hearing aid to be compared to prescription hearing aid

  • Prescription hearing aidDevice

    Prescription hearing aid used as active comparator to the OTC self-fitting hearing aid

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Abbreviated Profile of Hearing Aid Benefit (APHAB)Time frame: Baseline, three weeks and six weeks

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.